Kevin Roche

Epidemic events by age group, on a population rate basis.

Not much change in the distribution of epidemic events by age.

Another week of pretty flat events, with vaxed but not boosted looking better than either unvaxed or vaxed and boosted.

Even while overseas, the research summaries continue to flow.

Health care will do its share and then some to keep inflation high.

All the research summaries that are fit to print.

Another comparison of the multi-year epidemic reveals an apparent plateauing, but testing skews everything.

The population rate version of the age structure of the epidemic, which is a somewhat better way to look at trends by age.

Another update on the age structure as well--same old, same old--all the serious disease is in older folks.

Electricity rates are rising rapidly.

For the 65 and over age group, being vaxed and boosted appears to provide protection against serious disease.

Vaccines appear to do little to prevent infection in this age group, but do seem to inhibit serious disease.

For young adults, the vaccines have limited protection against infection, but do seem to limit serious disease.

For this group of older children, vaccines offer no protection from infection and likely no effect on hospitalization risk, which is extremely small to start with.

For young children, the data shows zero benefit from vaccination.